Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
40,830,830 7.600% |
-6,980,526 (-14.60%) |
Filing History |
| 2024-08-23 4:20 pm Sale |
2024-08-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
AMGEN INC AMGN |
0 0.000% |
-4,910,000 (Position Closed) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Amgen Inc. AMGN |
The Vanguard Group | 49,036,311 9.160% |
971,172 (+2.02%) |
Filing History |
| 2024-01-30 11:35 am Sale |
2023-12-31 | 13G | Amgen Inc. AMGN |
STATE STREET CORP STT |
29,543,705 5.520% |
-216,383 (-0.73%) |
Filing History |
| 2024-01-25 1:48 pm Sale |
2023-12-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
47,811,356 8.900% |
-701,723 (-1.45%) |
Filing History |
| 2023-09-27 07:30 am Purchase |
2023-09-19 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA |
AMGEN INC AMGN |
35,368,653 23.200% |
35,368,653 (New Position) |
Filing History |
| 2023-02-10 4:18 pm Sale |
2023-01-31 | 13G | Jasper Therapeutics, Inc. JSPR |
AMGEN INC AMGN |
100,993 0.900% |
-169,007 (-62.60%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Amgen Inc. AMGN |
The Vanguard Group | 48,065,139 9.010% |
1,404,130 (+3.01%) |
Filing History |
| 2023-02-07 2:10 pm Sale |
2022-12-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
48,513,079 9.100% |
-1,533,266 (-3.06%) |
Filing History |
| 2023-02-06 08:59 am Sale |
2022-12-31 | 13G | Amgen Inc. AMGN |
STATE STREET CORP STT |
29,760,088 5.580% |
-461,620 (-1.53%) |
Filing History |
| 2022-12-02 06:01 am Purchase |
2022-11-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
AMGEN INC AMGN |
4,910,000 6.000% |
4,910,000 (New Position) |
Filing History |
| 2022-02-11 12:22 pm Sale |
2022-02-14 | 13G | Amgen Inc. AMGN |
Capital Research Global Investors | 22,157,906 3.900% |
-9,604,421 (-30.24%) |
Filing History |
| 2022-02-10 2:17 pm Purchase |
2021-12-31 | 13G | Amgen Inc. AMGN |
STATE STREET CORP STT |
30,221,708 5.370% |
108,424 (+0.36%) |
Filing History |
| 2022-02-09 3:24 pm Sale |
2021-12-31 | 13G | Amgen Inc. AMGN |
The Vanguard Group | 46,661,009 8.280% |
-566,220 (-1.20%) |
Filing History |
| 2022-01-31 5:59 pm Purchase |
2021-12-31 | 13G | Amgen Inc. AMGN |
BLACKROCK INC BLK |
50,046,345 8.900% |
2,240,551 (+4.69%) |
Filing History |
| 2022-01-11 9:33 pm Purchase |
2022-01-11 | 13G | Vigil Neuroscience, Inc. VIGL |
AMGEN INC AMGN |
3,206,281 11.300% |
3,206,281 (New Position) |
Filing History |
| 2021-10-01 5:27 pm Purchase |
2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
AMGEN INC AMGN |
270,000 7.400% |
270,000 (New Position) |
Filing History |
| 2021-02-16 3:46 pm Sale |
2021-02-16 | 13G | Amgen Inc. AMGN |
Capital Research Global Investors | 31,762,327 5.500% |
-3,575,312 (-10.12%) |
Filing History |
| 2021-02-10 10:30 am Sale |
2020-12-31 | 13G | Amgen Inc. AMGN |
The Vanguard Group | 47,227,229 8.110% |
-1,244,296 (-2.57%) |
Filing History |
| 2021-02-05 4:35 pm Sale |
2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
AMGEN INC AMGN |
1,508,375 4.344% |
-397,323 (-20.85%) |
Filing History |